BSE Live
Oct 08, 16:01Prev. Close
48.48
Open Price
48.54
Bid Price (Qty.)
48.10 (10)
Offer Price (Qty.)
48.10 (50)
NSE Live
Oct 08, 15:58Prev. Close
48.50
Open Price
48.44
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
48.09 (151)
Key Financial Ratios of Morepen Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Sep 17 | Mar 17 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 0.75 | 0.64 | 0.66 | 0.27 | 0.53 | |
Diluted EPS (Rs.) | 0.75 | 0.64 | 0.66 | 0.27 | 0.53 | |
Cash EPS (Rs.) | 1.57 | 1.53 | 1.42 | 0.00 | 1.28 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 6.31 | 5.62 | 5.01 | 0.00 | 4.35 | |
Book Value [InclRevalReserve]/Share (Rs.) | 6.31 | 5.62 | 5.01 | 0.00 | 4.35 | |
Revenue from Operations/Share (Rs.) | 18.97 | 17.09 | 13.48 | 0.00 | 13.24 | |
PBDIT/Share (Rs.) | 1.73 | 1.58 | 1.52 | 0.00 | 1.45 | |
PBIT/Share (Rs.) | 0.91 | 0.70 | 0.76 | 0.00 | 0.69 | |
PBT/Share (Rs.) | 0.87 | 0.65 | 0.66 | 0.00 | 0.53 | |
Net Profit/Share (Rs.) | 0.75 | 0.64 | 0.66 | 0.00 | 0.53 | |
NP After MI And SOA / Share (Rs.) | 0.75 | 0.64 | 0.66 | 0.00 | 0.53 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 9.14 | 9.26 | 11.28 | 11.14 | 10.93 | |
PBIT Margin (%) | 4.81 | 4.07 | 5.62 | 5.35 | 5.23 | |
PBT Margin (%) | 4.58 | 3.79 | 4.90 | 4.41 | 3.96 | |
Net Profit Margin (%) | 3.93 | 3.75 | 4.90 | 4.40 | 3.96 | |
NP After MI And SOA Margin (%) | 3.93 | 3.75 | 4.87 | 4.40 | 3.96 | |
Return on Networth/Equity (%) | 11.82 | 11.39 | 13.09 | 0.00 | 12.04 | |
Return on Capital Employed (%) | 13.16 | 11.33 | 13.89 | 0.00 | 14.61 | |
Return on Assets (%) | 5.06 | 4.68 | 5.05 | 0.00 | 4.39 | |
Total Debt/Equity (X) | 0.04 | 0.04 | 0.79 | 0.00 | 0.64 | |
Asset Turnover Ratio (%) | 128.57 | 124.92 | 103.53 | 0.00 | 110.62 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.06 | 0.88 | 0.73 | 0.00 | 0.59 | |
Quick Ratio (X) | 0.66 | 0.61 | 0.50 | 0.00 | 0.39 | |
Inventory Turnover Ratio (X) | 6.16 | 8.16 | 7.89 | 0.00 | 9.21 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Coverage Ratios | ||||||
Interest Coverage Ratios (%) | 20.71 | 14.83 | 7.83 | 5.69 | 4.13 | |
Interest Coverage Ratios (Post Tax) (%) | 20.71 | 14.83 | 7.83 | 5.69 | 4.13 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 402.04 | 754.04 | 1,559.04 | 0.00 | 972.64 | |
EV/Net Operating Revenue (X) | 0.47 | 0.98 | 2.57 | 0.00 | 1.63 | |
EV/EBITDA (X) | 5.15 | 10.59 | 22.78 | 0.00 | 14.94 | |
MarketCap/Net Operating Revenue (X) | 0.50 | 1.01 | 2.29 | 0.00 | 1.44 | |
Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Price/BV (X) | 1.51 | 3.07 | 6.14 | 0.00 | 4.35 | |
Price/Net Operating Revenue | 0.50 | 1.01 | 2.29 | 0.00 | 1.44 | |
Earnings Yield | 0.08 | 0.04 | 0.02 | 0.00 | 0.03 |
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y
13.05.2025
Morepen Lab Standalone March 2025 Net Sales at Rs 381.94 crore, down 2.72% Y-o-Y
12.05.2025
Morepen Lab Consolidated March 2025 Net Sales at Rs 465.85 crore, up 10.11% Y-o-Y